April 2009 - Volume 19 - Issue 2 - Contributor Index

Alphabetical Search
J
K
N
V
Y
Author:
Aitini, Enrico

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Ridolfi, Laura; Fiorentini, Giammaria; Guida, Michele; More

Melanoma Research. 19(2):100-105, April 2009.

Author:
Akslen, Lars A.
Author:
Alaibac, Mauro
Author:
Alonso, Jose

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Ridolfi, Laura; Fiorentini, Giammaria; Guida, Michele; More

Melanoma Research. 19(2):100-105, April 2009.

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Ridolfi, Laura; Fiorentini, Giammaria; Guida, Michele; More

Melanoma Research. 19(2):100-105, April 2009.

Author:
Brady, Mary S.
Author:
Brown, Karen
Author:
Chen, Ni
Author:
Chen, Xueqin
Author:
Duffy, David L.
Author:
Engele, Ludmila

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Ridolfi, Laura; Fiorentini, Giammaria; Guida, Michele; More

Melanoma Research. 19(2):100-105, April 2009.

Author:
Fisher, Charles
Author:
Freschi, Andrea

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Ridolfi, Laura; Fiorentini, Giammaria; Guida, Michele; More

Melanoma Research. 19(2):100-105, April 2009.

Author:
Geng, Ning
Author:
Gong, Jing
Author:
Guida, Michele

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Ridolfi, Laura; Fiorentini, Giammaria; Guida, Michele; More

Melanoma Research. 19(2):100-105, April 2009.

Author:
Heisele, Olita
Author:
Henry, Kristin
Author:
Hu, Dan-Ning
Author:
Huang, Ying
Author:
Ito, Shosuke
Author:
Lam, Tai K.
Author:
Marx, Will
Author:
Michiara, Maria

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Ridolfi, Laura; Fiorentini, Giammaria; Guida, Michele; More

Melanoma Research. 19(2):100-105, April 2009.

Author:
Molven, Anders

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Ridolfi, Laura; Fiorentini, Giammaria; Guida, Michele; More

Melanoma Research. 19(2):100-105, April 2009.

Author:
Patel, Ami
Author:
Pjanova, Dace
Author:
Quigley, Mary
Author:
Retsas, Spyros
Author:
Ridolfi, Laura

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Ridolfi, Laura; Fiorentini, Giammaria; Guida, Michele; More

Melanoma Research. 19(2):100-105, April 2009.

Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients

Ridolfi, Laura; Fiorentini, Giammaria; Guida, Michele; More

Melanoma Research. 19(2):100-105, April 2009.

Author:
Uren, Roger F.
Author:
Wang, Lin
Author:
Wittig, Olga
Author:
Xu, Miao
Author:
Zattra, Edoardo
Author:
Zhao, Zhen Zhen
Author:
Zhou, Qiao
Author:
Zoras, Odysseas
Show: